vs

Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and John Marshall Bancorp, Inc. (JMSB). Click either name above to swap in a different company.

Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $16.8M, roughly 1.3× John Marshall Bancorp, Inc.). John Marshall Bancorp, Inc. runs the higher net margin — 36.3% vs -373.3%, a 409.6% gap on every dollar of revenue.

Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.

John Marshall Bancorp, Inc. is a U.S.-based bank holding company that operates through its wholly owned subsidiary John Marshall Bank. It provides a full suite of commercial and consumer banking products including deposit accounts, commercial loans, residential mortgages, and personal financial services, primarily serving retail customers and small-to-mid-sized businesses across the U.S. Mid-Atlantic region.

AUTL vs JMSB — Head-to-Head

Bigger by revenue
AUTL
AUTL
1.3× larger
AUTL
$21.2M
$16.8M
JMSB
Higher net margin
JMSB
JMSB
409.6% more per $
JMSB
36.3%
-373.3%
AUTL

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
AUTL
AUTL
JMSB
JMSB
Revenue
$21.2M
$16.8M
Net Profit
$-79.1M
$6.1M
Gross Margin
Operating Margin
-337.9%
Net Margin
-373.3%
36.3%
Revenue YoY
Net Profit YoY
3.6%
26.8%
EPS (diluted)
$-0.30
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AUTL
AUTL
JMSB
JMSB
Q1 26
$16.8M
Q4 25
$16.4M
Q3 25
$21.2M
$16.3M
Q2 25
$20.9M
$15.4M
Q1 25
$9.0M
$14.6M
Q4 24
$14.3M
Q3 24
$0
$13.8M
Q2 24
$0
$12.6M
Net Profit
AUTL
AUTL
JMSB
JMSB
Q1 26
$6.1M
Q4 25
$5.9M
Q3 25
$-79.1M
$5.4M
Q2 25
$-47.9M
$5.1M
Q1 25
$-70.2M
$4.8M
Q4 24
$4.8M
Q3 24
$-82.1M
$4.2M
Q2 24
$-58.3M
$3.9M
Operating Margin
AUTL
AUTL
JMSB
JMSB
Q1 26
Q4 25
47.4%
Q3 25
-337.9%
42.2%
Q2 25
-292.6%
42.7%
Q1 25
-726.3%
42.4%
Q4 24
42.5%
Q3 24
38.8%
Q2 24
39.7%
Net Margin
AUTL
AUTL
JMSB
JMSB
Q1 26
36.3%
Q4 25
36.2%
Q3 25
-373.3%
33.2%
Q2 25
-229.0%
33.1%
Q1 25
-781.1%
32.9%
Q4 24
33.3%
Q3 24
30.7%
Q2 24
30.9%
EPS (diluted)
AUTL
AUTL
JMSB
JMSB
Q1 26
$0.43
Q4 25
$0.41
Q3 25
$-0.30
$0.38
Q2 25
$-0.18
$0.36
Q1 25
$-0.26
$0.34
Q4 24
$0.33
Q3 24
$-0.31
$0.30
Q2 24
$-0.22
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AUTL
AUTL
JMSB
JMSB
Cash + ST InvestmentsLiquidity on hand
$86.1M
$150.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$265.5M
$268.1M
Total Assets
$661.9M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AUTL
AUTL
JMSB
JMSB
Q1 26
$150.2M
Q4 25
$130.0M
Q3 25
$86.1M
$163.6M
Q2 25
$123.8M
$116.9M
Q1 25
$95.8M
$169.1M
Q4 24
$122.5M
Q3 24
$657.1M
$177.2M
Q2 24
$705.9M
$182.6M
Total Debt
AUTL
AUTL
JMSB
JMSB
Q1 26
Q4 25
$80.9M
Q3 25
$80.9M
Q2 25
$80.8M
Q1 25
$80.8M
Q4 24
$80.8M
Q3 24
$80.8M
Q2 24
$24.7M
Stockholders' Equity
AUTL
AUTL
JMSB
JMSB
Q1 26
$268.1M
Q4 25
$265.6M
Q3 25
$265.5M
$259.7M
Q2 25
$346.5M
$253.7M
Q1 25
$371.1M
$253.0M
Q4 24
$246.6M
Q3 24
$477.0M
$243.1M
Q2 24
$527.8M
$235.3M
Total Assets
AUTL
AUTL
JMSB
JMSB
Q1 26
$2.4B
Q4 25
$2.3B
Q3 25
$661.9M
$2.3B
Q2 25
$721.0M
$2.3B
Q1 25
$746.3M
$2.3B
Q4 24
$2.2B
Q3 24
$827.5M
$2.3B
Q2 24
$853.6M
$2.3B
Debt / Equity
AUTL
AUTL
JMSB
JMSB
Q1 26
Q4 25
0.30×
Q3 25
0.31×
Q2 25
0.32×
Q1 25
0.32×
Q4 24
0.33×
Q3 24
0.33×
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AUTL
AUTL
JMSB
JMSB
Operating Cash FlowLast quarter
$-67.9M
Free Cash FlowOCF − Capex
$-72.3M
FCF MarginFCF / Revenue
-341.2%
Capex IntensityCapex / Revenue
20.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-322.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AUTL
AUTL
JMSB
JMSB
Q1 26
Q4 25
$22.6M
Q3 25
$-67.9M
$1.2M
Q2 25
$-72.8M
$7.5M
Q1 25
$-75.6M
$7.0M
Q4 24
$17.3M
Q3 24
$-76.7M
$1.4M
Q2 24
$-51.1M
$10.2M
Free Cash Flow
AUTL
AUTL
JMSB
JMSB
Q1 26
Q4 25
$22.0M
Q3 25
$-72.3M
$1.2M
Q2 25
$-80.1M
$7.4M
Q1 25
$-83.8M
$6.6M
Q4 24
$16.8M
Q3 24
$-86.3M
$1.3M
Q2 24
$-51.9M
$10.1M
FCF Margin
AUTL
AUTL
JMSB
JMSB
Q1 26
Q4 25
134.7%
Q3 25
-341.2%
7.3%
Q2 25
-382.6%
47.8%
Q1 25
-933.1%
45.3%
Q4 24
116.9%
Q3 24
9.5%
Q2 24
80.1%
Capex Intensity
AUTL
AUTL
JMSB
JMSB
Q1 26
Q4 25
3.4%
Q3 25
20.8%
0.2%
Q2 25
34.8%
1.0%
Q1 25
91.8%
2.3%
Q4 24
3.4%
Q3 24
0.8%
Q2 24
0.4%
Cash Conversion
AUTL
AUTL
JMSB
JMSB
Q1 26
Q4 25
3.82×
Q3 25
0.23×
Q2 25
1.48×
Q1 25
1.45×
Q4 24
3.61×
Q3 24
0.33×
Q2 24
2.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AUTL
AUTL

Segment breakdown not available.

JMSB
JMSB

Net Interest Income$16.5M98%
Noninterest Income$284.0K2%

Related Comparisons